Skip to main content
. 2012 Apr 1;13(6):358–368. doi: 10.4161/cbt.19241

Table 2. Polyamine content and epidermal thickness in TPA-treated skin from wild type and CAG-SpmS mice.

Tissue Treatment Genotype Polyamine content (pmol/mg tissue)
 
Thickness (µm)
Putrescine Spermidine Spermine Spm:Spd ratio
Epidermis
Acetone
Wild type
34 ± 25
163 ± 67
82 ± 20
0.53 ± 0.09
8.5 ± 0.4
CAG-SpmS
14 ± 6
72 ± 17
116 ± 32
1.60 ± 0.09c
10.4 ± 1.3a
 
TPA
Wild type
48 ± 19
392 ± 51
110 ± 30
0.28 ± 0.06
43.4 ± 7.8
CAG-SpmS
82 ± 35
279 ± 27b
253 ± 73b
0.90 ± 0.20c
42.3 ± 9.4
 
 
 
 
 
 
 
 
Dermis
Acetone
Wild type
67 ± 37
195 ± 56
82 ± 16
0.43 ± 0.07
 
 
CAG-SpmS
26 ± 12
87 ± 13a
99 ± 11
1.14 ± 0.07c
 
  TPA
Wild type
60 ± 37
350 ± 54
103 ± 24
0.29 ± 0.03
 
  CAG-SpmS 81 ± 59 187 ± 41c 162 ± 45a 0.86 ± 0.11c  

Polyamine content was determined in 7-week-old mice treated four times with acetone (n = 3 per genotype) or 17 nmol TPA (n = 5 per genotype). Skin was harvested 24h after the final treatment and processed for polyamine measurement or epidermal thickness (mean ± S.D.). ap < 0.05, bp < 0.005, cp < 0.001 vs. wild type controls.